Treatment for Group C Streptococcal Infection
Penicillin G is the antibiotic of choice for Group C streptococcal infections, with consideration for adding an aminoglycoside for serious invasive infections such as endocarditis, meningitis, septic arthritis, or bacteremia in neutropenic patients 1, 2.
Antibiotic Selection by Infection Severity
Mild to Moderate Infections (pharyngitis, uncomplicated skin/soft tissue)
- Penicillin G monotherapy is adequate for most cases 3, 1
- Group C streptococci remain highly susceptible to penicillin, similar to Group A streptococci
- Oral penicillin can be used for outpatient management of uncomplicated infections
Serious Invasive Infections
For endocarditis, meningitis, septic arthritis, or bacteremia (especially in neutropenic hosts):
- Combination therapy: Penicillin + aminoglycoside is recommended 4, 2
- This synergistic combination appears to reduce morbidity compared to penicillin alone, particularly important given that Group C streptococcal endocarditis has high rates of valve destruction and major embolic events 4
- Early valve replacement should be considered for endocarditis cases to reduce mortality 4
Important Caveats
Penicillin tolerance may occur - some Group C streptococci demonstrate tolerance (higher MBC:MIC ratios), which can lead to slow therapeutic response 1. For serious infections, obtain MIC and MBC testing to guide therapy duration and intensity.
Polymicrobial infections are common - 26% of Group C infections are nosocomial, and co-infection with gram-negative enteric bacilli frequently occurs 2. If clinical response is inadequate or the patient has risk factors (hospitalization, abdominal source, perineum involvement), broaden coverage empirically until cultures finalize.
Resistance patterns to monitor 3:
- Tetracyclines - resistance documented
- Macrolides - resistance documented
- Clindamycin - resistance documented
- These should NOT be used as first-line agents
Patient Risk Factors
Group C infections predominantly affect patients with:
- Chronic cardiopulmonary disease
- Diabetes mellitus
- Malignancy (especially neutropenic patients)
- Alcoholism
- Male gender 2
These underlying conditions influence both infection severity and treatment outcomes, requiring more aggressive initial therapy and longer treatment courses.
Duration and Route
- Serious infections: IV therapy initially, with extended courses (4-6 weeks for endocarditis, 2-4 weeks for bacteremia)
- Prosthetic joint infections: Surgical debridement + extended IV antibiotics followed by long-term oral penicillin suppression 5
- Uncomplicated infections: Standard 10-day courses similar to Group A streptococcal pharyngitis